SCHEMBL11264271

SCHEMBL11264271

Cc1ccc(C(=O)OC23CC4CC(C2)CC(C(=O)Oc2nc[nH]c2C(N)=O)(C4)C3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.41
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 3/20 0.39
ATM Q13315 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
PKM P14618 1/20 0.33
LMNA P02545 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HSP90AA1 P07900 2/20 0.32
CKS1B P61024 1/20 0.32
SKP1 P63208 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11264814 0.91 KMT2A (0.40) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL11263661 0.91 RAB9A (0.33) RAB9AMEN1KMT2AALDH1A1KDM4E
SCHEMBL11247393 0.91 KDM4E (0.35) RAB9AMEN1KMT2AALDH1A1KDM4E
SCHEMBL11249248 0.88 KMT2A (0.35) RAB9AMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL11267977 0.85 MEN1 (0.34) MEN1KMT2AALDH1A1KDM4EATM
SCHEMBL11127952 0.83 MEN1 (0.37) MEN1KMT2AALDH1A1KDM4EATM
SCHEMBL11261625 0.83 MEN1 (0.52) MEN1KMT2ALMNASMN1; SMN2GAA
SCHEMBL11265126 0.78 LMNA (0.39) MEN1KMT2AALDH1A1KDM4EATM
SCHEMBL11129141 0.78 ALDH1A1 (0.39) RAB9AMEN1KMT2AALDH1A1KDM4E
SCHEMBL11395198 0.77 GAA (0.46) RAB9AMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4332806-A Antitumor and immunosuppresive 4-carbamoyl imidazolium-5-olate derivatives, pharmaceutical composition and production thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-06-01 US disclosed
EP-0028936-A2 4-Carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-05-20 EP disclosed